A five-day course of ivermectin may reduce the duration of COVID-19 illness.

Ahmed, Sabeena; Khan, Wasif Ali

Ahmed, Sabeena; Khan, Wasif Ali.

Afiliação

Ahmed S; Senior Research Investigator, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Electronic address: sabeena@icddrb.org.
Khan WA; Scientist, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Electronic address: wakhan@icddrb.org.

Int J Infect Dis ; 110: 93-94, 2021 09.

Article em En | MEDLINE | ID: mdl-34325042

Assuntos

COVID-19; Ivermectina; Antivirais/uso terapêutico; Humanos; SARS-CoV-2

Palavras-chave

COVID-19; antiviral effect; ivermectin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ivermectina / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ivermectina / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article